Showing results (361-370 of 403) with videos related to

Sort By:
Pageof 41
Rheumatology (Oxford, England)|January 16, 2023
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAMSofia Ramiro, Robert Landewé, Désirée van der Heijde, et al.
JAMA|February 6, 2019
Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical TrialSigne Møller-Bisgaard, Kim Hørslev-Petersen, Bo Ejbjerg, et al.
RMD Open|February 20, 2025
Challenge of missing data in observational studies: investigating cross-sectional imputation methods for assessing disease activity in axial spondyloarthritisStylianos Georgiadis, Marion Pons, Simon Rasmussen, et al.
Arthritis Care & Research|June 26, 2024
Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European CountriesLouise Linde, Stylianos Georgiadis, Lykke M Ørnbjerg, et al.
Annals of the Rheumatic Diseases|June 4, 2021
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaborationUlf Lindström, Daniela Di Giuseppe, Bénédicte Delcoigne, et al.
Rheumatology (Oxford, England)|July 16, 2015
Effectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis: a cohort study of patients registered in the Danish biologics registryTanja Schjødt Jørgensen, Lars Erik Kristensen, Robin Christensen, et al.
The Journal of Rheumatology|September 3, 2019
Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RAWalter P Maksymowych, Oliver FitzGerald, Mikkel Østergaard, et al.
Lancet (London, England)|February 16, 2024
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trialJuergen Rech, Koray Tascilar, Melanie Hagen, et al.
Annals of the Rheumatic Diseases|August 19, 2019
MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working groupWalter P Maksymowych, Robert Gw Lambert, Mikkel Østergaard, et al.
The Journal of Rheumatology|January 15, 2024
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine CareLykke M Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, et al.
Pageof 41